Gian P. Caviglia
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 188 publications
MBOAT7 rs641738 TT genotype is associated with poorer survival in MASLD-related hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: July 07, 2026
Long-Term Feasibility, Adherence, and Exploratory Clinical Outcomes of Crohn's Disease Exclusion Diet Plus Partial Enteral Nutrition in Adults with Crohn's Disease.
Journal: Nutrients
Published: June 23, 2026
Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.
Journal: Journal of clinical medicine
Published: June 12, 2026
Clinical Outcomes After Ustekinumab Biosimilar Switching in Crohn's Disease: the USBIOS IG-IBD Study.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: June 05, 2026
Response to Letter to the Editor: "Enhancing the robustness of early vs late switch to subcutaneous infliximab in inflammatory bowel disease (IBD): the value of propensity score analysis".
Journal: Inflammatory bowel diseases
Published: February 04, 2026
Impact of weight loss and reduction of ultra-processed foods on liver fat content in MASLD: a randomized controlled trial.
Journal: JHEP reports : innovation in hepatology
Published: February 03, 2026
Changing Pattern of HDV Infection in Italy Over 40 Years; the Current Scenario and the Impending Challenge.
Journal: Journal of viral hepatitis
Published: December 15, 2025
Retrospective Analysis of Diagnostic and Prognostic Value of Serum Glypican-3 in Patients With HCV-Related Cirrhosis With Or Without HCC After Achieving SVR With DAA Treatment.
Journal: Journal of gastrointestinal cancer
Published: December 07, 2025
Soft drink consumption and liver fibrosis in type 2 diabetes.
Journal: Frontiers in nutrition
Published: October 15, 2025
Reply: "Early Switching to Subcutaneous Infliximab as a Pragmatic Strategy for Optimized Inflammatory Bowel Disease Care".
Journal: Inflammatory bowel diseases
Published: October 08, 2025
IL10 rs1800896 Genetic Variant Predicts Biochemical Remission in Inflammatory Bowel Disease Patients Undergoing Biologic Therapy.
Journal: Immunology
Published: August 11, 2025
Last Updated: 09/26/2026